Maria Vincenza Carriero
Maria Vincenza Carriero
National Cancer Institute of Naples
Verified email at
Cited by
Cited by
Tumor associated neutrophils. Their role in tumorigenesis, metastasis, prognosis and therapy
MT Masucci, M Minopoli, MV Carriero
Frontiers in oncology 9, 1146, 2019
The emerging role of neutrophil extracellular traps (NETs) in tumor progression and metastasis
MT Masucci, M Minopoli, S Del Vecchio, MV Carriero
Frontiers in immunology 11, 1749, 2020
In vivo detection of multidrug-resistant (MDR1) phenotype by technetium-99m sestamibi scan in untreated breast cancer patients
S Del Vecchio, A Ciarmiello, MI Potena, MV Carriero, C Mainolfi, G Botti, ...
European journal of nuclear medicine 24, 150-159, 1997
The urokinase plasminogen activator and its receptor
D Alfano, P Franco, I Vocca, N Gambi, V Pisa, A Mancini, M Caputi, ...
Thrombosis and haemostasis 93 (02), 205-211, 2005
Tumor clearance of technetium 99m-sestamibi as a predictor of response to neoadjuvant chemotherapy for locally advanced breast cancer (442 views)
A Ciarmiello, S Del Vecchio, P Silvestro, MI Potena, MV Carriero, ...
Journal Of Clinical Oncology (ISSN: 0732-183x) 16 (5), 1677-1683, 1998
Urokinase Receptor Interacts with αvβ5 Vitronectin Receptor, Promoting Urokinase-dependent Cell Migration in Breast Cancer
MV Carriero, SD Vecchio, M Capozzoli, P Franco, L Fontana, A Zannetti, ...
Cancer research 59 (20), 5307-5314, 1999
The cleavage of the urokinase receptor regulates its multiple functions
N Montuori, MV Carriero, S Salzano, G Rossi, P Ragno
Journal of biological chemistry 277 (49), 46932-46939, 2002
Coordinate up-regulation of Sp1 DNA-binding activity and urokinase receptor expression in breast carcinoma
A Zannetti, S Del Vecchio, MV Carriero, R Fonti, P Franco, G Botti, ...
Cancer research 60 (6), 1546-1551, 2000
Fractional retention of technetium-99m-sestamibi as an index of P-glycoprotein expression in untreated breast cancer patients
S Del Vecchio, A Ciarmiello, L Pace, MI Potena, MV Carriero, C Mainolfi, ...
Journal of Nuclear Medicine 38 (9), 1348-1351, 1997
Antimicrobial human beta-defensin-2 stimulates migration, proliferation and tube formation of human umbilical vein endothelial cells
A Baroni, G Donnarumma, I Paoletti, I Longanesi-Cattani, K Bifulco, ...
Peptides 30 (2), 267-272, 2009
Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization
C Selleri, N Montuori, P Ricci, V Visconte, MV Carriero, N Sidenius, ...
Blood 105 (5), 2198-2205, 2005
Human Urokinase Receptor Concentration in Malignant and Benign Breast Tumors by in Vitro Quantitative Autoradiography: Comparison with Urokinase Levels
S Del Vecchio, MP Stoppelli, MV Carriero, R Fonti, O Massa, PY Li, G Botti, ...
Cancer research 53 (13), 3198-3206, 1993
TGF-β1 exposure induces epithelial to mesenchymal transition both in CSCs and non-CSCs of the A549 cell line, leading to an increase of migration ability in the CD133+ A549 …
V Tirino, R Camerlingo, K Bifulco, E Irollo, R Montella, F Paino, G Sessa, ...
Cell death & disease 4 (5), e620-e620, 2013
Distribution of ferritin, transferrin and lactoferrin in breast carcinoma tissue.
R Rossiello, MV Carriero, GG Giordano
Journal of clinical pathology 37 (1), 51-55, 1984
Large oncosomes overexpressing integrin alpha-V promote prostate cancer adhesion and invasion via AKT activation
C Ciardiello, A Leone, P Lanuti, MS Roca, T Moccia, VR Minciacchi, ...
Journal of Experimental & Clinical Cancer Research 38, 1-16, 2019
Cripto‐1 overexpression leads to enhanced invasiveness and resistance to anoikis in human MCF‐7 breast cancer cells
N Normanno, AD Luca, C Bianco, MR Maiello, MV Carriero, A Rehman, ...
Journal of cellular physiology 198 (1), 31-39, 2004
Cross-talk between fMLP and vitronectin receptors triggered by urokinase receptor-derived SRSRY peptide
L Gargiulo, I Longanesi-Cattani, K Bifulco, P Franco, R Raiola, ...
Journal of Biological Chemistry 280 (26), 25225-25232, 2005
Tissue distribution of soluble and receptor-bound urokinase in human breast cancer using a panel of monoclonal antibodies
MV Carriero, P Franco, SD Vecchio, O Massa, G Botti, G D'Aiuto, ...
Cancer research 54 (20), 5445-5454, 1994
Urokinase receptor-dependent and-independent p56/59hck activation state is a molecular switch between myelomonocytic cell motility and adherence
F Chiaradonna, L Fontana, C Iavarone, MV Carriero, G Scholz, ...
The EMBO Journal 18 (11), 3013-3023, 1999
Vitronectin binding to urokinase receptor in human breast cancer.
MV Carriero, S Del Vecchio, P Franco, MI Potena, F Chiaradonna, G Botti, ...
Clinical cancer research: an official journal of the American Association …, 1997
The system can't perform the operation now. Try again later.
Articles 1–20